Internal Medicine, Medical Oncology · Belton, MO
NPI
1417165796
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
17053 S Outer Rd Fl 1
Belton, MO, 64012
Phone (816) 974-5050
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
752 services
Medicare patients, 2024
344
Average age 73
Drug cost, 2024
$4.5M
757 prescriptions
Company payments, 2025
$465
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed M Karim was code 99214 (office e&m - established), 486 times for 242 patients. In total Syed M Karim billed 752 services in 10 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 486 | 242 | $67.79 | $33K |
| 99232 Hospital E&M - Subsequent | Facility | 92 | 61 | $57.34 | $5,275 |
| 99204 Office E&M - New | Facility | 84 | 84 | $91.01 | $7,645 |
| 99223 Hospital E&M - Initial | Facility | 71 | 61 | $129.24 | $9,176 |
By year: 2022 $62K for 819 services; 2023 $65K for 860 services; 2024 $56K for 752 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed M Karim prescribed most often to Medicare patients was Anastrozole, with 108 prescriptions and refills. In total Syed M Karim wrote 757 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 108 | 315 | 33 | $3,196 |
| Warfarin Sodium Generic | 46 | 57 | Under 11 | $267 |
| Xarelto Rivaroxaban | 34 | 84 | 12 | $46K |
| Eliquis Apixaban | 32 | 52 | 12 | $29K |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $451K |
| Imbruvica Ibrutinib | 29 | 29 | Under 11 | $499K |
| Ondansetron Hcl Generic | 27 | 27 | 19 | $266 |
| Oxycodone Hcl Generic | 22 | 22 | Under 11 | $669 |
| Hydroxyurea Generic | 20 | 57 | Under 11 | $602 |
| Acyclovir Generic | 19 | 57 | Under 11 | $393 |
| Ibrance Palbociclib | 17 | 17 | Under 11 | $273K |
| Givlaari Givosiran Sodium | 17 | 17 | Under 11 | $1.5M |
| Imatinib Mesylate Generic | 16 | 20 | Under 11 | $66K |
| Lenalidomide Generic | 16 | 16 | Under 11 | $288K |
| Pomalyst Pomalidomide | 16 | 16 | Under 11 | $408K |
Brand drugs: - claims; generic drugs: 526 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed M Karim $465 ($465 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $121.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $121 |
| Pfizer Inc. PFE | 3 | $79.98 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $60.11 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $33.19 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $30.6 |
| Daiichi Sankyo Inc. 4568.T | 1 | $29.62 |
| GlaxoSmithKline, LLC. GSK | 1 | $22.9 |
| Eisai Inc. 4523.T | 1 | $21.28 |
| Genentech USA, Inc. ROG.SW | 1 | $20.99 |
| Celgene Corporation BMY | 1 | $16.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.